Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.39B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$790M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$648M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$411M |
| 5 |
Microsoft
MSFT
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$344M |
| 2 |
Consolidated Edison
ED
|
+$155M |
| 3 |
iShares MSCI United Kingdom ETF
EWU
|
+$154M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$146M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.52% |
| 2 | Financials | 5.73% |
| 3 | Healthcare | 5.63% |
| 4 | Communication Services | 4.65% |
| 5 | Consumer Discretionary | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4401
PUT
Polaris
PII
$3.99B
| $420K | ﹤0.01% |
4,600
-1,500
| -25% | -$137K |
|
4402
PUT
McCormick & Company Non-Voting
MKC
$14.1B
| $419K | ﹤0.01% |
5,400
-14,000
| -72% | -$1.08M |
|
4403
Voya Financial
VOYA
$9.2B
| $419K | ﹤0.01% |
7,579
-172,352
| -96% | -$9.23M |
|
|
FFG
4404
DELISTED
FBL Financial Group
FFG
| $419K | ﹤0.01% |
6,578
+3,540
| +117% | +$226K |
|
4405
PUT
Franklin Resources
BEN
$17.3B
| $418K | ﹤0.01% |
12,000
-69,700
| -85% | -$2.37M |
|
4406
CALL
Olin
OLN
$2.14B
| $418K | ﹤0.01% |
19,100
+17,400
| +1,024% | +$387K |
|
|
BIG
4407
CALL
DELISTED
Big Lots, Inc.
BIG
| $418K | ﹤0.01% |
14,600
+11,800
| +421% | +$394K |
|
|
CNR
4408
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $416K | ﹤0.01% |
71,216
-42,867
| -38% | -$238K |
|
|
FSB
4409
DELISTED
Franklin Financial Network, Inc.
FSB
| $416K | ﹤0.01% |
14,888
+6,439
| +76% | +$179K |
|
4410
Levi Strauss
LEVI
$9.35B
| $415K | ﹤0.01% |
+19,869
| New | +$437K |
|
|
TUP
4411
CALL
DELISTED
Tupperware Brands Corporation
TUP
| $415K | ﹤0.01% |
21,800
+2,900
| +15% | +$65.1K |
|
4412
CALL
Ryder
R
$10.1B
| $414K | ﹤0.01% |
7,100
+6,600
| +1,320% | +$393K |
|
4413
Silicon Laboratories
SLAB
$7.21B
| $414K | ﹤0.01% |
4,002
+2,702
| +208% | +$261K |
|
4414
Intellia Therapeutics
NTLA
$1.57B
| $413K | ﹤0.01% |
25,244
+15,725
| +165% | +$247K |
|
4415
SI-BONE Inc
SIBN
$813M
| $413K | ﹤0.01% |
20,307
+2,425
| +14% | +$41.6K |
|
|
SLCA
4416
CALL
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $413K | ﹤0.01% |
32,300
-12,400
| -28% | -$169K |
|
|
GOOD
4417
Gladstone Commercial Corp
GOOD
$625M
| $412K | ﹤0.01% |
19,411
+10,149
| +110% | +$216K |
|
|
HDV
4418
iShares Core High Dividend ETF
HDV
$14.8B
| $412K | ﹤0.01% |
21,795
-24,120
| -53% | -$452K |
|
4419
PCB Bancorp
PCB
$395M
| $412K | ﹤0.01% |
8,236
+4,696
| +133% | +$82.1K |
|
|
EMBJ
4420
Embraer S.A. ADS
EMBJ
$12.8B
| $411K | ﹤0.01% |
20,367
-95,115
| -82% | -$1.84M |
|
|
HTT
4421
CALL
High Templar Tech Ltd
HTT
$385M
| $411K | ﹤0.01% |
54,800
+39,000
| +247% | +$269K |
|
4422
CNB Financial Corp
CCNE
$1.04B
| $410K | ﹤0.01% |
14,553
+9,997
| +219% | +$269K |
|
4423
Digi International
DGII
$3.15B
| $410K | ﹤0.01% |
32,338
+12,231
| +61% | +$149K |
|
4424
GDS Holdings
GDS
$6.38B
| $410K | ﹤0.01% |
10,906
-17,334
| -61% | -$631K |
|
|
CBIO
4425
Crescent Biopharma
CBIO
$610M
| $410K | ﹤0.01% |
343
-204
| -37% | -$244K |
|
Similar funds
Barclays's Q2 2019 Portfolio in Review
As of Q2 2019, Barclays held 7,617 positions worth $163B, up 13% from $145B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $14.2B of net new capital in Q2 2019, opening 457 new positions and adding to 3,922 existing holdings. Its largest new stake was Dow Inc: 2,580,874 shares worth $127M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $344M trimmed.
- Barclays's largest Q2 2019 buy was Dow Inc: 2,580,874 shares worth $127M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $1.39B increase.
- Barclays's biggest Q2 2019 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $344M.
- Barclays fully exited Bemis in Q2 2019, selling an estimated $33.4M.
- Barclays's ten largest holdings make up 25% of its $163B portfolio in Q2 2019.
- Barclays opened 457 new positions and closed 572 in Q2 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.